|
시장보고서
상품코드
2088735
과학 데이터 관리 시장 : 제공 형태, 데이터 유형별, 도입 형태, 기술, 조직 규모, 용도, 최종 사용자별 예측(2026-2032년)Scientific Data Management Market by Offering Type, Data Type, Deployment Mode, Technology, Organization Size, Application, End User - Global Forecast 2026-2032 |
||||||
360iResearch
과학 데이터 관리 시장은 2032년까지 연평균 복합 성장률(CAGR) 9.17%로 246억 3,000만 달러 규모로 확대될 것으로 예측됩니다.
| 주요 시장 통계 | |
|---|---|
| 기준 연도 : 2025년 | 133억 3,000만 달러 |
| 추정 연도 : 2026년 | 143억 3,000만 달러 |
| 예측 연도 : 2032년 | 246억 3,000만 달러 |
| CAGR(%) | 9.17% |
과학 데이터 관리는 연구소, 임상 현장, 산업계의 연구개발, 그리고 공공 부문의 과학 분야에서 고부가가치 연구 데이터를 생성, 관리, 분석, 공유하는 조직에게 있어 전략적 역량이 되고 있습니다. 이 시장은 멀티오믹스, 이미징, 센서, 시뮬레이션 및 실세계 증거 데이터 세트의 급속한 확대와 더불어, 재현성, 데이터 무결성, 사이버 보안 및 규제 준수에 대한 요구가 높아짐에 따라 형성되고 있습니다.
과학 데이터 관리 현황은 파편화된 파일 저장 및 수작업에 의한 메타데이터 관리에서 통합되고 클라우드에 대응하며 표준 규격에 기반한 데이터 생태계로 전환되고 있습니다. 연구 기관에서는 서로 단절된 실험실 정보 시스템, 전자연구노트(ELN), 그리고 연동되지 않은 아카이브를, 장비 데이터, 실험 배경, 워크플로우 이력, 동의 기록, 분석 결과를 연계하는 통합 환경으로 대체하고 있습니다.
인공지능(AI)은 적절하게 관리된 과학 데이터의 가치를 높이는 한편, 관리가 미흡한 데이터 세트가 초래하는 위험을 여실히 드러내고 있습니다. 신약 개발, 재료 과학, 유전체학, 기후 과학, 임상 분석에 사용되는 머신러닝 모델에는 추적 가능하고, 라벨이 지정되어 있으며, 일관성이 확보되고, 거버넌스가 적용된 데이터가 필요합니다. 그 결과, 각 조직은 메타데이터 보강, 자동화된 품질 검사, 시맨틱 태깅, 프로반스 관리 등을 포함하는 AI 지원 데이터 파이프라인에 대한 투자를 추진하고 있습니다.
북미에서는 생명과학 분야의 강력한 연구개발, 학술 연구에 대한 자금 지원, 첨단 클라우드 인프라, 그리고 NIH의 데이터 관리 및 공유 정책 등의 조치에 힘입어 과학 데이터 관리의 도입이 촉진되고 있습니다. 미국은 기업 규모의 연구 데이터 플랫폼 분야에서 주도적인 입지를 차지하고 있는 반면, 캐나다는 연구 협력, 개인정보 보호 및 국가 차원의 디지털 연구 인프라를 중시하고 있습니다.
아세안(ASEAN) 국가들에서는 각국 정부가 디지털 헬스, 생명공학, 농업 기술 및 대학의 연구 역량을 확대함에 따라, 상호 운용이 가능하고 합리적인 가격의 과학 데이터 플랫폼에 대한 수요가 생겨나며 그 중요성이 커지고 있습니다. GCC 국가들은 국가 변혁 프로그램, 정밀의료 이니셔티브, 그리고 클라우드, AI, 연구 중심 대학에 대한 대규모 투자를 통해 데이터 기반 연구를 추진하고 있습니다.
미국은 제약 기업, 연방 연구 기관, 대학 부속 의료 센터, 국립 연구소 및 AI를 활용한 연구 개발이 집중되어 있어, 계속해서 주요 시장으로서의 위상을 유지하고 있습니다. 캐나다는 국가 연구 데이터 인프라 구축과 개인정보 보호를 고려한 공동 연구 강화에 힘쓰고 있습니다. 멕시코와 브라질은 공중보건, 농업 과학, 생물다양성, 환경 모니터링 및 임상 연구 활동을 바탕으로 라틴아메리카에서 중요한 시장입니다.
업계의 리더는 과학 데이터 관리를 단순한 부서 차원의 IT 프로젝트가 아닌, 엔터프라이즈 아키텍처의 우선 과제로 다뤄야 합니다. 첫 번째 조치로, 연구 라이프사이클 전반에 걸친 소유권, 메타데이터 표준, 보존 규칙, 동의 관리, 감사 가능성 및 FAIR 원칙 준수를 정의한, 거버넌스가 확립된 데이터 전략을 수립해야 합니다.
본 요약본은 정부 정책 문서, 규제 체계, 자금 지원 기관의 지침, 국제적인 오픈 사이언스 이니셔티브, 표준화 기구 및 공개된 업계 정보 등 검증된 공개 정보원을 바탕으로 한 2차 조사에 근거하고 있습니다. 본 분석에서는 생명과학, 의료 연구, 산업 연구 개발, 환경 과학, 학술 기관 및 정부 연구소의 과학 데이터 관리 도입 현황을 고려하고 있습니다.
과학 데이터 관리는 이제 연구 생산성, 규정 준수, 공동 연구, 그리고 AI를 활용한 발견을 실현하기 위한 핵심 요소가 되었습니다. 파편화된 데이터 세트를 신뢰성이 높고 상호 운용 가능하며 재사용 가능한 자산으로 전환할 수 있는 조직은 투명성, 보안, 재현성에 대한 높아지는 기대에 부응하면서 혁신을 가속화하는 데 있어 더 유리한 입지를 확보할 수 있을 것입니다.
The Scientific Data Management Market is projected to grow by USD 24.63 billion at a CAGR of 9.17% by 2032.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2025] | USD 13.33 billion |
| Estimated Year [2026] | USD 14.33 billion |
| Forecast Year [2032] | USD 24.63 billion |
| CAGR (%) | 9.17% |
Scientific data management has become a strategic capability for organizations that generate, curate, analyze, and share high-value research data across laboratories, clinical environments, industrial R&D, and public-sector science. The market is being shaped by the rapid growth of multi-omics, imaging, sensor, simulation, and real-world evidence datasets, alongside rising requirements for reproducibility, data integrity, cybersecurity, and regulatory compliance.
Executive buyers are prioritizing platforms that support FAIR data principles-findable, accessible, interoperable, and reusable-while also aligning with mandates such as the NIH Data Management and Sharing Policy, GDPR, FDA 21 CFR Part 11, HIPAA where applicable, and evolving open science frameworks promoted by organizations such as UNESCO and the OECD. As research becomes more collaborative and computationally intensive, scientific data management solutions are moving from back-office repositories to mission-critical infrastructure for innovation, compliance, and AI readiness.
The scientific data management landscape is shifting from fragmented file storage and manual metadata practices toward integrated, cloud-enabled, and standards-based data ecosystems. Research organizations are replacing siloed laboratory information systems, electronic lab notebooks, and disconnected archives with unified environments that connect instrument data, experimental context, workflow history, consent records, and analytical outputs.
A second major shift is the rise of governed data sharing. Funding agencies, regulators, and journals increasingly expect research data to be documented, preserved, and shared when ethically and legally permissible. This is accelerating investment in metadata automation, persistent identifiers, data lineage, audit trails, controlled access, and interoperability standards such as HL7 FHIR in health data, CDISC in clinical research, and domain-specific ontologies across life sciences, earth sciences, engineering, and physical sciences.
Artificial intelligence is increasing the value of well-managed scientific data while exposing the risks of poorly curated datasets. Machine learning models used in drug discovery, materials science, genomics, climate science, and clinical analytics require data that is traceable, labeled, harmonized, and governed. As a result, organizations are investing in AI-ready data pipelines that include metadata enrichment, automated quality checks, semantic tagging, and provenance management.
The cumulative impact of AI is also changing operating models. Generative AI can assist researchers with literature review, protocol drafting, code generation, and data discovery, but trustworthy adoption depends on validated datasets, model governance, privacy controls, and human oversight. Scientific data management platforms that combine access control, explainability support, versioning, and reproducible workflows are becoming essential for responsible AI deployment in research-intensive industries.
In North America, scientific data management adoption is supported by strong life sciences R&D, academic research funding, advanced cloud infrastructure, and policies such as the NIH Data Management and Sharing Policy. The United States leads in enterprise-scale research data platforms, while Canada emphasizes research collaboration, privacy protection, and national digital research infrastructure.
Europe is shaped by GDPR, the European Open Science Cloud, Horizon Europe priorities, and strong public research networks, making compliance, sovereignty, and interoperability central buying criteria. Asia-Pacific is expanding rapidly as China, Japan, India, South Korea, Australia, and ASEAN economies increase investments in genomics, clinical trials, advanced manufacturing, and AI-enabled science. Latin America is building capacity around public health, biodiversity, agriculture, and academic research data modernization, with Brazil and Mexico as key anchors.
The Middle East is investing in precision medicine, energy research, smart cities, and national AI strategies, particularly across GCC economies. Africa is advancing scientific data management through public health surveillance, pathogen genomics, climate resilience, agricultural research, and regional research networks, with demand rising for scalable, secure, and cost-effective platforms that support cross-border collaboration and local data stewardship.
ASEAN is gaining relevance as governments expand digital health, biotechnology, agriculture technology, and university research capacity, creating demand for interoperable and affordable scientific data platforms. The GCC is advancing data-driven research through national transformation programs, precision medicine initiatives, and major investments in cloud, AI, and research universities.
The European Union is one of the most influential groups for scientific data management because its regulatory and policy frameworks-especially GDPR, the Data Governance Act, the Data Act, and the European Open Science Cloud-shape procurement expectations for privacy, consent, portability, and trusted data sharing. BRICS countries are expanding research infrastructure and digital sovereignty priorities, creating opportunities for localized deployments, multilingual metadata, and scalable data governance.
G7 economies remain central to advanced scientific computing, pharmaceutical innovation, regulatory science, and research data standardization. NATO members increasingly view data integrity, cyber resilience, and secure scientific collaboration as strategic priorities, especially for defense research, biosecurity, space, environmental monitoring, and dual-use technologies.
The United States remains a leading market due to its concentration of pharmaceutical companies, federal research agencies, academic medical centers, national laboratories, and AI-driven R&D. Canada is strengthening national research data infrastructure and privacy-aware collaboration. Mexico and Brazil are important Latin American markets, supported by public health, agricultural science, biodiversity, environmental monitoring, and clinical research activity.
In Europe, the United Kingdom emphasizes life sciences innovation, genomics, and research excellence; Germany focuses on engineering, industrial R&D, and regulated data environments; France advances health data, AI, and public research modernization; Italy and Spain are expanding clinical, academic, and biomedical data capabilities; and Russia maintains demand across energy, defense, space, and scientific computing despite geopolitical constraints.
In Asia-Pacific, China is scaling research data management across genomics, AI, manufacturing, and clinical development; India is accelerating adoption through digital public infrastructure, pharmaceutical research, and expanding biotech activity; Japan prioritizes quality, traceability, and advanced materials and healthcare research; South Korea combines strong semiconductor, biotech, and digital health capabilities; and Australia is supported by genomics, environmental science, clinical research, and national research infrastructure.
Industry leaders should treat scientific data management as an enterprise architecture priority rather than a departmental IT project. The first action is to create a governed data strategy that defines ownership, metadata standards, retention rules, consent management, auditability, and FAIR alignment across the research lifecycle.
Organizations should modernize toward cloud-hybrid architectures that support secure collaboration while retaining control over regulated and sensitive datasets. Leaders should also invest in AI-ready data foundations, including automated quality controls, ontology management, data lineage, reproducible workflows, and model governance. Vendor selection should prioritize open APIs, standards compatibility, cybersecurity certifications, configurable compliance, and proven integration with laboratory instruments, ELNs, LIMS, clinical systems, repositories, and analytics platforms.
This executive summary is based on secondary research of verified public sources, including government policy documents, regulatory frameworks, funding agency guidance, international open science initiatives, standards bodies, and publicly available industry disclosures. The analysis considers scientific data management adoption across life sciences, healthcare research, industrial R&D, environmental science, academic institutions, and government laboratories.
The methodology applies triangulation across regulatory signals, technology adoption trends, regional research priorities, and enterprise procurement drivers. Emphasis is placed on data-backed indicators such as formal policy mandates, recognized standards, national research infrastructure programs, and documented shifts toward AI, cloud computing, open science, and regulated data sharing.
Scientific data management is now a core enabler of research productivity, compliance, collaboration, and AI-driven discovery. Organizations that can transform fragmented datasets into trusted, interoperable, and reusable assets will be better positioned to accelerate innovation while meeting rising expectations for transparency, security, and reproducibility.
The strongest opportunities will emerge for platforms that combine FAIR data practices, regulatory-grade governance, AI readiness, and flexible deployment models. As scientific collaboration becomes more global and data-intensive, the ability to manage research data with integrity and intelligence will define competitive advantage across the scientific ecosystem.